Cargando…
Risk and benefit for umbrella trials in oncology: a systematic review and meta-analysis
BACKGROUND: Umbrella clinical trials in precision oncology are designed to tailor therapies to the specific genetic changes within a tumor. Little is known about the risk/benefit ratio for umbrella clinical trials. The aim of our systematic review with meta-analysis was to evaluate the efficacy and...
Autores principales: | Strzebonska, Karolina, Blukacz, Mateusz, Wasylewski, Mateusz T., Polak, Maciej, Gyawali, Bishal, Waligora, Marcin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264503/ https://www.ncbi.nlm.nih.gov/pubmed/35799149 http://dx.doi.org/10.1186/s12916-022-02420-2 |
Ejemplares similares
-
Risk and Benefit for Targeted Therapy Agents in Pediatric Phase II Trials in Oncology: A Systematic Review with a Meta-Analysis
por: Strzebonska, Karolina, et al.
Publicado: (2021) -
Clinical development success rates and social value of pediatric Phase 1 trials in oncology
por: Wasylewski, Mateusz T., et al.
Publicado: (2020) -
Umbrella and basket trials in oncology: ethical challenges
por: Strzebonska, Karolina, et al.
Publicado: (2019) -
Risk and surrogate benefit for pediatric Phase I trials in oncology: A systematic review with meta-analysis
por: Waligora, Marcin, et al.
Publicado: (2018) -
Results dissemination of registered clinical trials across Polish academic institutions: a cross-sectional analysis
por: Strzebonska, Karolina, et al.
Publicado: (2020)